Trial Profile
Phase II/III trial of MSB-CAR001 in patients with ACL reconstruction
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 13 Apr 2016
Price :
$35
*
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Ligament injuries; Osteoarthritis
- Focus Registrational; Therapeutic Use
- 13 Apr 2016 New trial record